POU2F3 and in situ carcinoma: For example, three series of spots identified as Lox (spots 31–35, Figure 3A), PLA1 (spots 36, 39 and 40) and Lap (spots 47–50) showed higher expression in pool CIS-t compared to pool CIS-s.